In the present work, a series of novel isatin-indole conjugates (7a-j and 9a-e) was designed and synthesised as potential antiproliferative agents towards colon cancer cells with promising inhibitory activity against the anti-apoptotic Bcl2 and BclxL proteins. This evidence concerns the gene BCL2 and colonic neoplasm.